BB&T Upgraded to Overweight at Evercore Partners (BBT)

Share on StockTwits

BB&T (NYSE: BBT) was upgraded by equities researchers at Evercore Partners to an “overweight” rating in a research report issued on Monday, StockRatingsNetwork reports.

BBT has been the subject of a number of other recent research reports. Analysts at Wunderlich raised their price target on shares of BB&T from $35.00 to $38.00 in a research note to investors on Monday, June 3rd. They now have a “buy” rating on the stock. Separately, analysts at Sanford C. Bernstein reiterated a “market perform” rating on shares of BB&T in a research note to investors on Tuesday, May 28th. They now have a $35.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of BB&T in a research note to investors on Friday, May 24th. They now have a $34.50 price target on the stock.

Nineteen equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $34.70.

Shares of BB&T (NYSE: BBT) opened at 33.23 on Monday. BB&T has a 52 week low of $26.86 and a 52 week high of $34.37. The stock’s 50-day moving average is currently $31.81. The company has a market cap of $23.317 billion and a P/E ratio of 13.97.

BB&T (NYSE: BBT) last announced its earnings results on Thursday, April 18th. The company reported $0.69 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.63 by $0.06. The company had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.46 billion. During the same quarter in the prior year, the company posted $0.61 earnings per share. The company’s quarterly revenue was up 4.9% on a year-over-year basis. On average, analysts predict that BB&T will post $2.91 earnings per share for the current fiscal year.

BB&T Corporation (NYSE: BBT) is a financial holding company.

Latest News

Horizon Pharma Moves Overseas Defying Lawmakers
Horizon Pharma Moves Overseas Defying Lawmakers
Apple Frenzy as Stores Start Selling iPhone 6
Apple Frenzy as Stores Start Selling iPhone 6
GlaxoSmithKline Fined Close to $500 Million by China
GlaxoSmithKline Fined Close to $500 Million by China
Japan Sees Another Trade Deficit
Japan Sees Another Trade Deficit
Sony Says Losses Will Reach $2 Billion
Sony Says Losses Will Reach $2 Billion
UK Inflation Drops During August
UK Inflation Drops During August


Leave a Reply

 
 
© 2006-2014 Ticker Report. Google+.